GTCR and Corza Health Merge Surgical Specialties and TachoSil to Create Corza Medical
February 1, 2021
GTCR, together with management partner Gregory T. Lucier (Corza Health), acquired Surgical Specialties Corporation and the TachoSil fibrin sealant patch product line from Takeda and merged them to form Corza Medical. The new company, headquartered in Westwood, Massachusetts, operates in 13 countries with manufacturing in the U.S., Mexico, England, Germany and China and a global team of over 1,700 employees.
- Buyers
- GTCR, Corza Health (management partnership led by Gregory T. Lucier)
- Targets
- Surgical Specialties Corporation, TachoSil (fibrin sealant patch product line)
- Sellers
- Takeda Pharmaceutical Company Limited, Vivo Capital and an investor syndicate, ZQ Capital
- Platforms
- Corza Medical
- Industry
- Medical Devices
- Location
- Massachusetts, United States
- Transaction Type
- Buyout
Explore More
Related Acquisitions
-
EQT X to Acquire Corza Biosurgery (TachoSil) from Corza Medical
July 10, 2026
Healthcare Services
EQT X has agreed to acquire Corza Biosurgery, the biosurgery business unit centered on the TachoSil biologic hemostat and tissue-sealing patch, from Corza Medical. The deal is expected to close in Q4 2026, with EQT planning to invest in commercial acceleration, innovation, and geographic/indication expansion.
-
Solventum Completes Acquisition of Acera Surgical
December 23, 2025
Healthcare Services
Solventum completed its acquisition of Acera Surgical, a privately held bioscience company focused on regenerative wound care. The deal includes $725 million in upfront cash plus up to $125 million in contingent cash payments tied to future milestones.
-
GTCR Affiliate Acquires Surmodics, Inc.
November 10, 2025
Medical Devices
Surmodics announced that a U.S. district court denied the FTC and certain state regulators’ request for a preliminary injunction to block the company’s proposed acquisition by an affiliate of GTCR. Surmodics said the merger remains subject to a temporary restraining order and customary closing conditions, with the company expecting to move toward closing promptly.
-
GTCR Invests in Biocoat
November 2, 2022
Medical Devices
GTCR has made a strategic, majority recapitalization investment in Biocoat Holdings, LLC, a Horsham, Pennsylvania-based provider of biocompatible hydrophilic coatings and dip-coating equipment for medical devices. Existing investor 1315 Capital and Biocoat management retain minority stakes; GTCR will partner with CEO Jim Moran and add industry veteran Chip Hance as Executive Chairman to support growth, capability expansion and follow-on acquisitions.
-
Corza Medical (GTCR Portfolio) Acquires Barron Precision Instruments
June 8, 2022
Medical Devices
GTCR-backed Corza Medical has acquired Barron Precision Instruments (BPI), a founder-owned manufacturer of disposable ophthalmic surgery devices based in Grand Blanc, Michigan. The add-on expands Corza's ophthalmology portfolio and manufacturing footprint, supporting its Corza Ophthalmology business unit and GTCR's continued buildout of the platform.
-
Corza Medical (GTCR Portfolio Company) Acquires Katena Products from Audax Private Equity
December 2, 2021
Medical Devices
Corza Medical, a GTCR portfolio company, has acquired Katena Products from Audax Private Equity. Katena is a Parsippany, New Jersey–based manufacturer of precision ophthalmic instruments, single-use devices and specialty biologics with more than 200 employees and sales in over 110 countries. Audax, which acquired Katena in 2015, supported the company's operational and M&A-driven growth during its ownership.
Build a buyer list for your deal
Find active buyers from recent acquisition patterns and move straight into outreach.